{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T21:18:10Z","timestamp":1790543890563,"version":"4.1.0"},"reference-count":259,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice &amp; Research Clinical Endocrinology &amp; Metabolism"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.beem.2014.07.002","type":"journal-article","created":{"date-parts":[[2014,7,18]],"date-time":"2014-07-18T04:31:50Z","timestamp":1405657910000},"page":"911-935","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":59,"title":["Secondary osteoporosis: Pathophysiology &amp; diagnosis"],"prefix":"10.1016","volume":"28","author":[{"given":"Gregory R.","family":"Emkey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sol","family":"Epstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.beem.2014.07.002_bib1","first-page":"44","article-title":"Clinical practice: glucocorticoid-induced bone disease","volume":"364","author":"Weinstein","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.beem.2014.07.002_bib2","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s00198-005-1923-3","article-title":"High-dose glucocorticoid treatment induces rapid loss of trabecular bone mineral density and lean body mass","volume":"17","author":"Natsui","year":"2006","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.beem.2014.07.002_bib3","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1007\/s00198-007-0394-0","article-title":"Glucocorticoid-induced osteoporosis: pathophysiology and therapy","volume":"18","author":"Canalis","year":"2007","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.beem.2014.07.002_bib4","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s00198-003-1548-3","article-title":"Oral glucocorticoid use is associated with an increased risk of fracture","volume":"15","author":"Steinbuch","year":"2004","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.beem.2014.07.002_bib5","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.bone.2006.02.005","article-title":"High prevalence of asymptomatic vertebral fractures in postmenopausal women receiving chronic glucocorticoid therapy: a cross-sectional outpatient study","volume":"39","author":"Angeli","year":"2006","journal-title":"Bone"},{"key":"10.1016\/j.beem.2014.07.002_bib6","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1172\/JCI2799","article-title":"Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteoclasts by glucocorticoids. Potential mechanism of their deleterious effects on bone","volume":"102","author":"Weinstein","year":"1998","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.beem.2014.07.002_bib7","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1210\/en.2003-0990","article-title":"Glucocorticoids act directly on osteoblasts and osteocytes to induce their apoptosis and reduce bone formation and strength","volume":"145","author":"O\u2019Brien","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/j.beem.2014.07.002_bib8","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.bbrc.2005.01.117","article-title":"Glucocorticoid suppresses the canonical Wnt signal in cultured human osteoblasts","volume":"329","author":"Ohnaka","year":"2005","journal-title":"Biochem Biophys Rev Commun"},{"key":"10.1016\/j.beem.2014.07.002_bib9","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.bone.2013.08.016","article-title":"Effect of glucocorticoid treatment on Wnt signalling antagonists (sclerostin and Dkk-1) and their relationship with bone turnover","volume":"57","author":"Gifre","year":"2013","journal-title":"Bone"},{"key":"10.1016\/j.beem.2014.07.002_bib10","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1474-9726.2009.00545.x","article-title":"Endogenous glucocorticoids decrease skeletal angiogenesis, vascularity, hydration, and strength in aged mice","volume":"9","author":"Weinstein","year":"2010","journal-title":"Aging Cell"},{"key":"10.1016\/j.beem.2014.07.002_bib11","doi-asserted-by":"crossref","first-page":"4382","DOI":"10.1210\/endo.140.10.7034","article-title":"Stimulation of osteoprotegerin ligand and inhibition of osteoprotegerin production by glucocorticoids in human osteoblastic lineage cells: potential paracrine mechanisms of glucocorticoid-induced osteoporosis","volume":"140","author":"Hofbauer","year":"1999","journal-title":"Endocrinology"},{"key":"10.1016\/j.beem.2014.07.002_bib12","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.bone.2005.10.004","article-title":"Effects of dissociated glucocorticoids on OPG and RANKL in osteoblastic cells","volume":"38","author":"Humphrey","year":"2006","journal-title":"Bone"},{"key":"10.1016\/j.beem.2014.07.002_bib13","doi-asserted-by":"crossref","first-page":"5592","DOI":"10.1210\/en.2006-0459","article-title":"Glucocorticoids act directly on osteoclasts to increase their lifespan and reduce bone density","volume":"147","author":"Jia","year":"2006","journal-title":"Endocrinology"},{"key":"10.1016\/j.beem.2014.07.002_bib14","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0169-6009(91)90139-Q","article-title":"Bone loss in response to long-term glucocorticoid therapy","volume":"8","author":"LoCascio","year":"1990","journal-title":"Bone Min"},{"key":"10.1016\/j.beem.2014.07.002_bib15","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1056\/NEJM199807303390502","article-title":"Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis","volume":"339","author":"Saag","year":"1998","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.beem.2014.07.002_bib16","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.ecl.2012.04.004","article-title":"Glucocorticoid-induced osteoporosis and osteonecrosis","volume":"41","author":"Weinstein","year":"2012","journal-title":"Endocrinol Metab Clin Am"},{"key":"10.1016\/j.beem.2014.07.002_bib17","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1210\/jc.2008-1763","article-title":"Third international workshop on the management asymptomatic hyperparathyroidism","volume":"94","author":"Bilezikian","year":"2009","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2014.07.002_bib18","first-page":"184","article-title":"Primary hyperparathyroidism: pathophysiology and impact on bone","volume":"163","author":"Khan","year":"2000","journal-title":"CMAJ"},{"key":"10.1016\/j.beem.2014.07.002_bib19","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1359\/jbmr.070120","article-title":"New observations on bone quality in mild primary hyperparathyroidism as determined by quantitative backscattered electron imaging","volume":"22","author":"Roschger","year":"2007","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.beem.2014.07.002_bib20","doi-asserted-by":"crossref","first-page":"3484","DOI":"10.1210\/jc.2008-0530","article-title":"Bone quality determined by Fourier transform infrared imaging analysis in mild primary hyperparathyroidism","volume":"93","author":"Zoehrer","year":"2008","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2014.07.002_bib21","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1055\/s-0033-1349842","article-title":"Osteoprotegerin, RANKL, and bone-turnover in primary hyperparathyroidism: the effect of parathyroidectomy and treatment with alendronate","volume":"45","author":"Szymczak","year":"2013","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.beem.2014.07.002_bib22","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1055\/s-0031-1275661","article-title":"Comparisons of serum sclerostin levels among patients with postmenopausal osteoprosis, primary hyperparathyroidism, and osteomalacia","volume":"119","author":"Kaji","year":"2011","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/j.beem.2014.07.002_bib23","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1007\/s00223-012-9665-7","article-title":"Sclerostin and DKK1 in primary hyperparathyroidism","volume":"92","author":"Viapiana","year":"2013","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.beem.2014.07.002_bib24","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1089\/105072503322238854","article-title":"Hyperthyroidism, bone mineral, and fracture risk: a meta-analysis","volume":"13","author":"Vestergaard","year":"2003","journal-title":"Thyroid"},{"key":"10.1016\/j.beem.2014.07.002_bib25","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1089\/thy.1994.4.319","article-title":"Hyperthyroidism, thyroid hormone therapy, and bone","volume":"4","author":"Ross","year":"1994","journal-title":"Thyroid"},{"key":"10.1016\/j.beem.2014.07.002_bib26","doi-asserted-by":"crossref","first-page":"750","DOI":"10.7326\/0003-4819-130-9-199905040-00016","article-title":"The effect of thyroid hormone on skeletal integrity","volume":"130","author":"Greenspan","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.beem.2014.07.002_bib27","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1530\/EJE-09-0139","article-title":"Hyperthyroid levels of TSH correlate with low bone mineral density: the HUNT 2 study","volume":"161","author":"Svare","year":"2009","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2014.07.002_bib28","doi-asserted-by":"crossref","first-page":"561","DOI":"10.7326\/0003-4819-134-7-200104030-00009","article-title":"Risk for fracture in women with low thyroid-stimulating hormone","volume":"134","author":"Bauer","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.beem.2014.07.002_bib29","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0092-8674(03)00771-2","volume":"115","author":"Abe","year":"2003","journal-title":"Cell"},{"key":"10.1016\/j.beem.2014.07.002_bib30","doi-asserted-by":"crossref","first-page":"988","DOI":"10.4158\/EP12280.GL","article-title":"Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association","volume":"18","author":"Garber","year":"2012","journal-title":"Endocr Pract"},{"key":"10.1016\/j.beem.2014.07.002_bib31","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1210\/er.2007-0036","article-title":"Growth hormone, insulin-like growth factors, and the skeleton","volume":"29","author":"Giustina","year":"2008","journal-title":"Endocr Rev"},{"key":"10.1016\/j.beem.2014.07.002_bib32","first-page":"49","article-title":"The effects of growth hormone on cortical and cancellous bone","volume":"2","author":"Andreassen","year":"2001","journal-title":"J\u00a0Musculoskelet Neuronal Interact"},{"key":"10.1016\/j.beem.2014.07.002_bib33","doi-asserted-by":"crossref","first-page":"438","DOI":"10.3109\/08977190903299270","article-title":"A\u00a0general IGF-1 overexpression effectively rescued somatic growth and bone deficiency in mice caused by growth hormone receptor knockout","volume":"27","author":"De Jesus","year":"2009","journal-title":"Growth Factors"},{"key":"10.1016\/j.beem.2014.07.002_bib34","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/8756-3282(96)00069-5","article-title":"Histomorphometric analysis of bone mass and bone metabolism in growth hormone deficient adult men","volume":"18","author":"Bravenboer","year":"1996","journal-title":"Bone"},{"key":"10.1016\/j.beem.2014.07.002_bib35","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1359\/jbmr.2001.16.2.398","article-title":"The influence of growth hormone deficiency, growth hormone replacement therapy, and other aspects of hypopituitarism on fracture rate and bone mineral density","volume":"16","author":"Wuster","year":"2001","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.beem.2014.07.002_bib36","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1530\/eje.1.02285","article-title":"Serum GH and IGF-1 are significant determinants of bone turnover but not bone mineral density in active acromegaly: a prospective study of more than 70 consecutive patients","volume":"155","author":"Ueland","year":"2006","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2014.07.002_bib37","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1007\/BF01622293","article-title":"Osteopenia occurs in a minority of patients with acromegaly and is predominant in the spine","volume":"7","author":"Kayath","year":"1997","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.beem.2014.07.002_bib38","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1046\/j.1365-2265.2003.01777.x","article-title":"Bone mineral density in acromegaly: the effect of gender, disease activity and gonadal status","volume":"58","author":"Scillitani","year":"2003","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.beem.2014.07.002_bib39","doi-asserted-by":"crossref","first-page":"3402","DOI":"10.1210\/jc.2013-1460","article-title":"Vertebral fractures in patients with acromegaly: a 3-year prospective study","volume":"98","author":"Mazziotti","year":"2013","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2014.07.002_bib40","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1359\/JBMR.050603","article-title":"Increased prevalence of radiological spinal deformities in active acromegaly: a cross-sectional study in postmenopausal women","volume":"20","author":"Bonadonna","year":"2005","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.beem.2014.07.002_bib41","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.steroids.2008.10.003","article-title":"Androgens and bone","volume":"74","author":"Clarke","year":"2009","journal-title":"Steroids"},{"key":"10.1016\/j.beem.2014.07.002_bib42","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1365-2265.2004.02174.x","article-title":"Normal, bound, and nonbound testosterone levels in normal aging men: results from the Massachusetts male aging study","volume":"62","author":"Mohr","year":"2005","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.beem.2014.07.002_bib43","doi-asserted-by":"crossref","first-page":"421","DOI":"10.2165\/00002512-199813060-00002","article-title":"Osteoporosis in men. New insights into aetiology, pathogenesis, prevention, and management","volume":"13","author":"Ebeling","year":"1998","journal-title":"Drugs Aging"},{"key":"10.1016\/j.beem.2014.07.002_bib44","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1210\/endo-124-3-1576","article-title":"Androgens directly stimulate proliferation of bone cells in\u00a0vitro","volume":"124","author":"Kasperk","year":"1989","journal-title":"Endocrinology"},{"key":"10.1016\/j.beem.2014.07.002_bib45","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1359\/jbmr.1997.12.3.464","article-title":"Gonadal and adrenal androgens are potent regulators of human bone cell metabolism in\u00a0vitro","volume":"12","author":"Casperk","year":"1997","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.beem.2014.07.002_bib46","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1210\/edrv.23.3.0465","article-title":"Sex steroids and the construction and conservation of the adult skeleton","volume":"23","author":"Riggs","year":"2002","journal-title":"Endocr Rev"},{"key":"10.1016\/j.beem.2014.07.002_bib47","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1210\/jc.2002-021036","article-title":"Differential effect of androgens and estrogens on bone turnover in normal men","volume":"88","author":"Leder","year":"2003","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2014.07.002_bib48","first-page":"2266","article-title":"Relationship of serum sex steroid levels and bone turnover markers with bone mineral density in men and women: a key role for bioavailable estrogen","volume":"83","author":"Khosla","year":"1998","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2014.07.002_bib49","doi-asserted-by":"crossref","first-page":"951","DOI":"10.7326\/0003-4819-133-12-200012190-00010","article-title":"Association of hypogonadism and estradiol levels with bone mineral density in elderly men from the Framingham study","volume":"19","author":"Amin","year":"2000","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.beem.2014.07.002_bib50","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1210\/jc.2008-0668","article-title":"Relation between serum testosterone, serum estradiol, sex-hormone binding globulin, and geometric measures of adult male proximal femur strength","volume":"94","author":"Travison","year":"2009","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2014.07.002_bib51","doi-asserted-by":"crossref","first-page":"3337","DOI":"10.1210\/jc.2009-0206","article-title":"The effects of serum testosterone, estradiol, and sex hormone binding globulin on fracture risk in older men","volume":"94","author":"LeBlanc","year":"2009","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2014.07.002_bib52","first-page":"219","article-title":"Low levels of estradiol are associated with vertebral fractures in older men, but not women: the Rancho Bernardo Study","volume":"85","author":"Barrett-Connor","year":"2000","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2014.07.002_bib53","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1023\/B:REMD.0000032415.83124.20","article-title":"Osteoporosis and diabetes mellitus","volume":"5","author":"Inzerillo","year":"2004","journal-title":"Rev Endocr Metab Disord"},{"key":"10.1016\/j.beem.2014.07.002_bib54","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.bone.2008.03.017","article-title":"Diabetes and fragility fractures \u2013 a burgeoning epidemic?","volume":"43","author":"Epstein","year":"2008","journal-title":"Bone"},{"key":"10.1016\/j.beem.2014.07.002_bib55","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.2337\/diacare.24.7.1192","article-title":"Type 1 and type 2 diabetes and incident hip fractures in postmenopausal women","volume":"24","author":"Nicodemus","year":"2001","journal-title":"Diabetes Care"},{"key":"10.1016\/j.beem.2014.07.002_bib56","doi-asserted-by":"crossref","first-page":"3404","DOI":"10.1210\/jc.2006-0614","article-title":"Risk of fracture in women with type 2 diabetes: the Women's Health Initiative Observational Study","volume":"91","author":"Bonds","year":"2006","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2014.07.002_bib57","article-title":"Association between bone mineral density and type 1 diabetes mellitus: a meta-analysis of cross-sectional studies","author":"Pan","year":"2013","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.beem.2014.07.002_bib58","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s10654-012-9674-x","article-title":"Association between bone mineral density and type 2 diabetes mellitus: a meta-analysis of observational studies","volume":"27","author":"Ma","year":"2012","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.beem.2014.07.002_bib59","doi-asserted-by":"crossref","first-page":"5045","DOI":"10.1210\/jc.2010-0226","article-title":"High resolution peripheral quantitative computed tomographic imaging of cortical and trabecular bone microarchitecture in patients with type 2 diabetes mellitus","volume":"95","author":"Burghardt","year":"2010","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2014.07.002_bib60","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1002\/jbmr.2106","article-title":"In\u00a0vivo assessment of bone quality in postmenopausal women with type 2 diabetes","volume":"29","author":"Farr","year":"2014","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.beem.2014.07.002_bib61","first-page":"1190","article-title":"Influence of age, sex, and insulin on osteoblast function: osteoblast dysfunction in diabetes mellitus","volume":"80","author":"Bouillon","year":"1995","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2014.07.002_bib62","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/BF03343726","article-title":"Osteopenia in insulin-dependent diabetes mellitus; prevalence and aspects of pathophysiology","volume":"23","author":"Kemink","year":"2000","journal-title":"J\u00a0Endocrinol Invest"},{"key":"10.1016\/j.beem.2014.07.002_bib63","first-page":"S1","article-title":"Contributions of the insulin\/insulin-like growth factor-1 axis to diabetic osteopathy","volume":"1","author":"Fowlkes","year":"2011","journal-title":"J\u00a0Diabetes Metab"},{"key":"10.1016\/j.beem.2014.07.002_bib64","first-page":"455","article-title":"Insulin-dependent diabetes mellitus decreases osteoblastogenesis associated with the inhibition of Wnt signaling through increased expression of Sost and Dkk1 and inhibition of Akt activation","volume":"28","author":"Hie","year":"2011","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.beem.2014.07.002_bib65","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.bone.2013.10.001","article-title":"Collagen advanced glycation inhibitis its discoidin domain receptor 2-mediated induction of lysyl oxidase in osteoblasts","volume":"58","author":"Khosravi","year":"2014","journal-title":"Bone"},{"key":"10.1016\/j.beem.2014.07.002_bib66","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/ncprheum0070","article-title":"Mechanisms of disease: is osteoporosis the obesity of bone?","volume":"2","author":"Rosen","year":"2006","journal-title":"Nat Clin Pract Rheumatol"},{"key":"10.1016\/j.beem.2014.07.002_bib67","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/nrendo.2010.155","article-title":"PPARg: a circadian transcription factor in adipogenesis and osteogenesis","volume":"6","author":"Kawai","year":"2010","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.beem.2014.07.002_bib68","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1007\/s00198-005-1909-1","article-title":"Bone mineral density and fracture risk in type-2 diabetes mellitus: the Rotterdam Study","volume":"16","author":"de Liefde","year":"2005","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.beem.2014.07.002_bib69","doi-asserted-by":"crossref","first-page":"E436","DOI":"10.1210\/jc.2010-1886","article-title":"Relationship between vitamin D, parathyroid hormone, and bone health","volume":"96","author":"Sai","year":"2011","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2014.07.002_bib70","doi-asserted-by":"crossref","first-page":"1706S","DOI":"10.1093\/ajcn\/80.6.1706S","article-title":"Functional indices of vitamin D status and ramifications of vitamin D deficiency","volume":"80","author":"Heaney","year":"2004","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.beem.2014.07.002_bib71","doi-asserted-by":"crossref","first-page":"4982","DOI":"10.1210\/endo.140.11.7110","article-title":"Rescue of skeletal phenotype of vitamin D receptor-ablated mice in the setting of normal mineral ion homeostasis: formal histomorphometric and biochemical analyses","volume":"140","author":"Amling","year":"1999","journal-title":"Endocrinology"},{"key":"10.1016\/j.beem.2014.07.002_bib72","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.amjmed.2003.12.029","article-title":"Positive association between 25-hydroxy vitamin D levels and bone mineral density; a population-based study of younger and older adults","volume":"1","author":"Bischoff-Ferrari","year":"2004","journal-title":"Am J Med"},{"key":"10.1016\/j.beem.2014.07.002_bib73","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1210\/jcem.86.3.7327","article-title":"A\u00a0global study of vitamin D status and parathyroid function in postmenopausal women with osteoprosis: baseline data from the multiple outcomes of raloxifene evaluation clinical trial","volume":"86","author":"Lips","year":"2001","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2014.07.002_bib74","doi-asserted-by":"crossref","first-page":"242","DOI":"10.7326\/0003-4819-149-4-200808190-00005","article-title":"Serum 25-hydroxyvitamin D concentration and risk for hip fractures","volume":"149","author":"Cauley","year":"2008","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.beem.2014.07.002_bib75","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1359\/jbmr.090826","article-title":"Serum 25-hydroxyvitamin D and the risk of hip and non-spine fractures in older men","volume":"25","author":"Cauley","year":"2010","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.beem.2014.07.002_bib76","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1359\/jbmr.071003","article-title":"Serum 25-hydroxyvitamin D and hip fracture risk in older U.S. white adults","volume":"23","author":"Looker","year":"2008","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.beem.2014.07.002_bib77","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1093\/ajcn\/80.3.752","volume":"80","author":"Bischoff-Ferrari","year":"2004","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.beem.2014.07.002_bib78","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1136\/ard.2003.018127","article-title":"Prevalence and predictors of fragility fractures in systemic lupus erythematosus","volume":"64","author":"Yee","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.beem.2014.07.002_bib79","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/acr.20568","article-title":"Osteoporosis and fractures in systemic lupus erythematosus","volume":"64","author":"Bultink","year":"2012","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.beem.2014.07.002_bib80","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s11926-010-0106-1","article-title":"Vitamin D and systemic lupus erythematosus: bones, muscles, and joints","volume":"12","author":"Land","year":"2010","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.beem.2014.07.002_bib81","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1177\/0961203313498802","article-title":"SLE disease per se contributes to deterioration in bone mineral density, microstructure, and bone strength","volume":"22","author":"Tang","year":"2013","journal-title":"Lupus"},{"key":"10.1016\/j.beem.2014.07.002_bib82","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/j.0105-2896.2005.00338.x","article-title":"Rheumatic diseases: the effects of inflammation on bone","volume":"208","author":"Walsh","year":"2005","journal-title":"Immunol Rev"},{"key":"10.1016\/j.beem.2014.07.002_bib83","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1002\/1529-0131(199905)42:5<882::AID-ANR6>3.0.CO;2-C","article-title":"Frequency of fractures in women with systemic lupus erythematosus: comparison with United States population data","volume":"42","author":"Ramsey-Goldman","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.beem.2014.07.002_bib84","first-page":"2018","article-title":"Self-reported fractures and associated factors in women with systemic lupus erythematosus","volume":"34","author":"Lee","year":"2007","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.beem.2014.07.002_bib85","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1136\/ard.2003.016253","article-title":"Bone mineral density in patients with rheumatoid arthritis: relation between disease severity and low bone mineral density","volume":"63","author":"Lodder","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.beem.2014.07.002_bib86","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1002\/art.24551","article-title":"The relationship between focal erosions and generalized osteoporosis in postmenopausal women with osteoporosis","volume":"60","author":"Solomon","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.beem.2014.07.002_bib87","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/ar67","article-title":"Mechanisms of bone loss in inflammatory arthritis: diagnosis and therapeutic implications","volume":"2","author":"Goldring","year":"2000","journal-title":"Arthritis Res"},{"key":"10.1016\/j.beem.2014.07.002_bib88","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1002\/art.21896","article-title":"The ratio of circulating osteoprotegerin to RANKL in early rheumatoid arthritis predicts later joint destruction","volume":"54","author":"Geusens","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.beem.2014.07.002_bib89","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1136\/ard.2009.121764","article-title":"Baseline RANKL: OPG ratio and markers of bone and cartilage degradation predict annual radiological progression over 11 years in rheumatoid arthritis","volume":"69","author":"van Tuyl","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.beem.2014.07.002_bib90","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1136\/ard.2005.044198","article-title":"Evaluation of bone mineral density, bone metabolism, osteoprotegerin, and receptor activator of the NFkappaB ligand serum levels during treatment with infliximab in patients with rheumatoid arthritis","volume":"65","author":"Vis","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.beem.2014.07.002_bib91","first-page":"921","article-title":"Early effects of IL-6 receptor inhibition on bone homeostasis: a pilot study in women with rheumatoid arthritis","volume":"29","author":"Terpos","year":"2011","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.beem.2014.07.002_bib92","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.bone.2008.12.028","article-title":"Prevalence and risk factors of osteoporosis and vertebral fractures in patients with ankylosing spondylitis","volume":"44","author":"Ghozlani","year":"2009","journal-title":"Bone"},{"key":"10.1016\/j.beem.2014.07.002_bib93","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1007\/s10067-012-2018-0","article-title":"High prevalence of low bone mineral density in patients within 10 years of onset of ankylosing spondylitis: a systematic review","volume":"31","author":"van der Weijdan","year":"2012","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.beem.2014.07.002_bib94","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1093\/rheumatology\/39.1.85","article-title":"The prevalence of vertebral fractures in mild ankylosing spondylitis and their relationship to bone mineral density","volume":"39","author":"Mitra","year":"2000","journal-title":"Rheumatology"},{"key":"10.1016\/j.beem.2014.07.002_bib95","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1007\/s00296-011-1981-0","article-title":"Dickkopf-1level is lower in patients with ankylosing spondylitis than in healthy people and is not influenced by anti-tumor necrosis therapy","volume":"32","author":"Kwon","year":"2012","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.beem.2014.07.002_bib96","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3109\/03009742.2013.805241","article-title":"Effect of tumour necrosis factor-a inhibitor on serum level of dickkopf-1 protein and bone morphogenetic protein-7 in ankylosing spondylitis patients with high disease activity","volume":"43","author":"Korkosz","year":"2014","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.beem.2014.07.002_bib97","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/00002060-199801000-00005","article-title":"Bone mineral density and indexes of bone metabolism in spinal cord injury","volume":"77","author":"Szollar","year":"1998","journal-title":"Am J Phys Med Rehabil"},{"key":"10.1016\/j.beem.2014.07.002_bib98","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/s00198-003-1529-6","article-title":"Long-term changes in bone metabolism, bone mineral density, quantitative ultrasound parameters, and fracture incidence after spinal cord injury: a cross-sectional observational study in 100 paraplegic men","volume":"15","author":"Zehnder","year":"2004","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.beem.2014.07.002_bib99","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/8756-3282(89)90052-5","article-title":"Osteopenia in the immobilized rat limb is associated with increased bone resorption and decreased bone formation","volume":"10","author":"Weinreb","year":"1989","journal-title":"Bone"},{"key":"10.1016\/j.beem.2014.07.002_bib100","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/BF02555744","article-title":"Bone remodeling during the development of osteoporosis in paraplegia","volume":"38","author":"Chantraine","year":"1986","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.beem.2014.07.002_bib101","first-page":"415","article-title":"Longitudinal study of bone turnover after acute spinal cord injury","volume":"83","author":"Roberts","year":"1998","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2014.07.002_bib102","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.jbspin.2010.12.005","article-title":"Down-regulation of the Wnt, estrogen receptor, insulin-like growth factor-1, and bone morphogenetic protein pathways in osteoblasts from rats with chronic spinal cord injury","volume":"78","author":"Jiant","year":"2011","journal-title":"Jt Bone Spine"},{"key":"10.1016\/j.beem.2014.07.002_bib103","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1210\/jc.2010-0067","article-title":"Increased sclerostin serum levels associated with bone formation and resorption markers in patients with immobilization-induced bone loss","volume":"95","author":"Gaudio","year":"2010","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2014.07.002_bib104","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/S0140-6736(00)02217-0","article-title":"Effects of long-term microgravity exposure on cancellous and cortical weight-bearing bones of cosmonauts","volume":"355","author":"Vico","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.beem.2014.07.002_bib105","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1002\/mds.21598","article-title":"A\u00a0meta-analysis of six prospective studies of falling in Parkinson's disease","volume":"15","author":"Pickering","year":"2007","journal-title":"Mov Disord"},{"key":"10.1016\/j.beem.2014.07.002_bib106","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1093\/ageing\/afp137","article-title":"Bone and mineral metabolism in older adults with Parkinson's disease","volume":"38","author":"Abou-Raya","year":"2009","journal-title":"Age Ageing"},{"key":"10.1016\/j.beem.2014.07.002_bib107","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1093\/ageing\/21.1.32","article-title":"Fracture risk in patients with parkinsonism: a population-based study in Olmstead County, Minnesota","volume":"21","author":"Johnell","year":"1992","journal-title":"Age Ageing"},{"key":"10.1016\/j.beem.2014.07.002_bib108","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.parkreldis.2009.02.009","article-title":"Osteoporosis in Parkinson's disease","volume":"15","author":"Invernizzi","year":"2009","journal-title":"Park Relat Disord"},{"key":"10.1016\/j.beem.2014.07.002_bib109","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.jbspin.2004.04.012","article-title":"Parkinson's disease and osteoporosis","volume":"72","author":"Vasserman","year":"2005","journal-title":"Jt Bone Spine"},{"key":"10.1016\/j.beem.2014.07.002_bib110","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s00774-005-0604-9","article-title":"Vitamin D deficiency and reduced bone mineral density in multiple sclerosis: effect of ambulatory status and functional capacity","volume":"23","author":"Ozgocmen","year":"2005","journal-title":"J\u00a0Bone Min Metab"},{"key":"10.1016\/j.beem.2014.07.002_bib111","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1191\/1352458504ms993oa","article-title":"Risk of bone loss in men with multiple sclerosis","volume":"10","author":"Weinstock-Guttman","year":"2004","journal-title":"Mult Scler"},{"key":"10.1016\/j.beem.2014.07.002_bib112","first-page":"19","article-title":"Factors affecting bone mineral density in multiple sclerosis patients","volume":"12","author":"Ayatollahi","year":"2013","journal-title":"Iran J Neurol"},{"key":"10.1016\/j.beem.2014.07.002_bib113","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/j.bone.2012.02.639","article-title":"Effect of co-morbidities on fracture risk: findings from Global Longitudinal Study of Osteoporosis in Women (GLOW)","volume":"50","author":"Dennison","year":"2012","journal-title":"Bone"},{"key":"10.1016\/j.beem.2014.07.002_bib114","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1212\/WNL.44.9.1687","article-title":"High prevalence of vitamin D deficiency and reduced bone mass in multiple sclerosis","volume":"44","author":"Nieves","year":"1994","journal-title":"Neurology"},{"key":"10.1016\/j.beem.2014.07.002_bib115","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4065\/78.1.21","article-title":"Review of 1027 patients with newly diagnosed multiple myeloma","volume":"78","author":"Kyle","year":"2003","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.beem.2014.07.002_bib116","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.bcmd.2004.01.001","article-title":"Pathogenesis of myeloma bone disease","volume":"32","author":"Roodman","year":"2004","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/j.beem.2014.07.002_bib117","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1634\/stemcells.2005-0220","article-title":"A\u00a0crosstalk between myeloma cells and marrow stromal cells stimulates production of Dkk-1 in IL-6: a potential role in the development of lytic bone disease and tumor progression in multiple myeloma","volume":"24","author":"Gunn","year":"2006","journal-title":"Stem Cells"},{"key":"10.1016\/j.beem.2014.07.002_bib118","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.exphem.2004.03.015","article-title":"New insight in the mechanism of osteoclast activation and formation in multiple myeloma: focus on the receptor activator of NF-KappaB ligand","volume":"32","author":"Giuliani","year":"2004","journal-title":"Exp Hematol"},{"key":"10.1016\/j.beem.2014.07.002_bib119","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1182\/blood.V96.2.671.014k24_671_675","article-title":"Macrophage inflammatory protein 1-alpha is a potential osteoclast stimulatory factor in multiple myeloma","volume":"96","author":"Choi","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.beem.2014.07.002_bib120","doi-asserted-by":"crossref","first-page":"3527","DOI":"10.1182\/blood.V98.13.3527","article-title":"Myeloma cells indue imbalance in the osteoprotegerin\/osteoprotegerin ligand system in the human bone marrow environment","volume":"15","author":"Giuliani","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.beem.2014.07.002_bib121","doi-asserted-by":"crossref","first-page":"3568","DOI":"10.1182\/blood-2002-08-2383","article-title":"Macrophage inflammatory protein 1-alpha triggers migration and signaling cascades mediating survival and proliferation in multiple myeloma cells","volume":"101","author":"Lentzsch","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.beem.2014.07.002_bib122","doi-asserted-by":"crossref","first-page":"333","DOI":"10.3324\/haematol.2010.031302","article-title":"A\u00a0prospective evaluation of the biochemical, metabolic, hormonal and structural bone changes associated with bortezomib response in multiple myeloma patients","volume":"96","author":"Zangari","year":"2011","journal-title":"Haemotologica"},{"key":"10.1016\/j.beem.2014.07.002_bib123","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1056\/NEJMoa030847","article-title":"The role of Wnt-signaling antagonist DKK1in the development of osteolytic lesions in multiple myeloma","volume":"349","author":"Tian","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.beem.2014.07.002_bib124","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1359\/jbmr.081104","article-title":"Inhibiting DKK1 removes suppression of bone formation and prevents the development of osteolytic bone disease in multiple myeloma","volume":"24","author":"Heath","year":"2009","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.beem.2014.07.002_bib125","doi-asserted-by":"crossref","first-page":"685","DOI":"10.4065\/84.8.685","article-title":"Disease associations of monoclonal gammopathy of undetermined significance: a population-based study of 17,398 patients","volume":"84","author":"Bida","year":"2009","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.beem.2014.07.002_bib126","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1359\/jbmr.0301212","article-title":"Fracture risk in monoclonal gammopathy of undetermined significance","volume":"19","author":"Melton","year":"2004","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.beem.2014.07.002_bib127","doi-asserted-by":"crossref","first-page":"6529","DOI":"10.1182\/blood-2011-04-351437","article-title":"Bone microstructural changes revealed by high-resolution peripheral quantitative computed tomography imaging and elevated DKK1 and MIP-1alpha levels in patients with MGUS","volume":"118","author":"Ng","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.beem.2014.07.002_bib128","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1111\/j.1365-2141.2004.05092.x","article-title":"Role of RANKL, osteoprotegerin, and macrophage protein 1-alpha in monoclonal gammopathy of undetermined significance","volume":"126","author":"Politou","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1016\/j.beem.2014.07.002_bib129","first-page":"167","article-title":"Osteoporosis in thalassemia major: an update and the I-CET 2013 recommendations for surveillance and treatment","volume":"11","author":"De Sanctis","year":"2013","journal-title":"Pediatr Endocrinol Rev"},{"key":"10.1016\/j.beem.2014.07.002_bib130","first-page":"5","article-title":"Pathophysiology of bone modifications in B-thalassemia","volume":"2012","author":"Perisiano","year":"2012","journal-title":"Anemia"},{"key":"10.1016\/j.beem.2014.07.002_bib131","doi-asserted-by":"crossref","first-page":"3966","DOI":"10.1210\/jc.2002-021548","article-title":"Bone histomorphometry in children and adolescents with beta-thalassemia disease: iron-associated focal osteomalacia","volume":"88","author":"Mahachoklerwattana","year":"2003","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2014.07.002_bib132","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1055\/s-0032-1312618","article-title":"High circulating sclerostin is present in patients with thalassemia-associated osteoporosis and correlates with bone mineral density","volume":"44","author":"Voskaridou","year":"2012","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.beem.2014.07.002_bib133","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1016\/j.bone.2007.02.020","article-title":"The \u201clively\u201d cytokines network in beta-thalassemia major-related osteoporosis","volume":"40","author":"Morabito","year":"2007","journal-title":"Bone"},{"key":"10.1016\/j.beem.2014.07.002_bib134","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.bone.2011.07.004","article-title":"Bone mineral density, bone turnover markers and fractures in patients with indolent systemic mastocytosis","volume":"49","author":"Rossini","year":"2011","journal-title":"Bone"},{"key":"10.1016\/j.beem.2014.07.002_bib135","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/S8756-3282(02)00875-X","article-title":"A\u00a0potential role for the mast cell in the pathogenesis of idiopathic osteoporosis in men","volume":"31","author":"Brumsen","year":"2002","journal-title":"Bone"},{"key":"10.1016\/j.beem.2014.07.002_bib136","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.semarthrit.2006.03.004","article-title":"The role of mast cells in osteoporosis","volume":"36","author":"Chiappetta","year":"2006","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.beem.2014.07.002_bib137","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1159\/000063858","article-title":"Serum interleukin-6 reflects disease severity and osteoporosis in mastocytosis patients","volume":"128","author":"Theoharides","year":"2002","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.beem.2014.07.002_bib138","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1097\/QAD.0b013e32801022eb","article-title":"Antiretroviral therapy and the prevalence of osteopenia in osteoporosis: a meta-analytic review","volume":"20","author":"Brown","year":"2006","journal-title":"Aids"},{"key":"10.1016\/j.beem.2014.07.002_bib139","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1002\/jbmr.1874","article-title":"HIV infection is strongly associated with hip fracture risk, independently of age, gender, and comorbidities: a population-based cohort study","volume":"28","author":"Guerri-Fernandez","year":"2013","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.beem.2014.07.002_bib140","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.bone.2013.07.019","article-title":"Impact of antiretroviral therapy on bone metabolism markers in HIV-seropositive patients","volume":"57","author":"de Menezes Barbosa","year":"2013","journal-title":"Bone"},{"key":"10.1016\/j.beem.2014.07.002_bib141","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1097\/QAD.0b013e328359a8ca","volume":"26","author":"Yin","year":"2012","journal-title":"AIDS"},{"key":"10.1016\/j.beem.2014.07.002_bib142","first-page":"571418","article-title":"HIV and bone disease: a perspective of the role of microRNAs in bone biology upon HIV infection","author":"Del Carpio-Cano","year":"2013","journal-title":"J\u00a0Osteoporos"},{"key":"10.1016\/j.beem.2014.07.002_bib143","doi-asserted-by":"crossref","first-page":"48251","DOI":"10.1074\/jbc.M304676200","article-title":"HIV envelope gp120-mediated regulation of osteoclastogenesis via receptor activator of nuclear factor kappa B ligand secretion and its modulation by certain HIV protease inhibitors through interferon-gamma\/RANKL cross-talk","volume":"278","author":"Fakruddin","year":"2003","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.beem.2014.07.002_bib144","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s00705-004-0395-7","article-title":"HIV-1 Vpr enhances production of RANKL via potentiation of glucocorticoid receptor activity","volume":"150","author":"Fakruddin","year":"2005","journal-title":"Arch Virol"},{"key":"10.1016\/j.beem.2014.07.002_bib145","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1086\/498511","article-title":"Bone disease and HIV infection","volume":"42","author":"Amorosa","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.beem.2014.07.002_bib146","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1182\/blood-2004-08-3058","article-title":"TNR-related apoptosis-inducing ligand in HIV-1 infected patients and its in\u00a0vitro production by antigen-presenting cells","volume":"105","author":"Herbeuval","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.beem.2014.07.002_bib147","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/ki.2010.473","article-title":"Nephrolithiasis-associated bone disease: pathogenesis and treatment options","volume":"79","author":"Sakhaee","year":"2011","journal-title":"Kidney Int"},{"key":"10.1016\/j.beem.2014.07.002_bib148","doi-asserted-by":"crossref","first-page":"c89","DOI":"10.1159\/000072491","article-title":"Bone mineral density in girls and their mothers with idiopathic hypercalciuria","volume":"94","author":"Garcia-Nieto","year":"2003","journal-title":"Nephron Clin Pract"},{"key":"10.1016\/j.beem.2014.07.002_bib149","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1046\/j.1523-1755.1998.00779.x","article-title":"Fracture risk among patients with urolithiasis: a population-based cohort study","volume":"53","author":"Melton","year":"1998","journal-title":"Kidney Int"},{"key":"10.1016\/j.beem.2014.07.002_bib150","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.ecl.2012.05.005","article-title":"Unrecognized and unappreciated secondary causes of osteoporosis","volume":"41","author":"Miller","year":"2012","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.beem.2014.07.002_bib151","first-page":"CD005185","article-title":"Thiazide diuretics and the risk of hip fracture","volume":"10","author":"Aung","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.beem.2014.07.002_bib152","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1210\/jcem-50-4-654","article-title":"Abnormal bone histology in idiopathic hypercalciuria","volume":"50","author":"Malluche","year":"1980","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2014.07.002_bib153","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/01.mnh.0000232880.58340.0c","article-title":"Bone disease in idiopathic hypercalciuria","volume":"15","author":"Heilberg","year":"2006","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.beem.2014.07.002_bib154","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1111\/j.1523-1755.2005.00685.x","article-title":"Effect of dietary modification on urinary stone risk factors","volume":"68","author":"Pak","year":"2005","journal-title":"Kidney Int"},{"key":"10.1016\/j.beem.2014.07.002_bib155","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0002-9343(82)90567-8","article-title":"Effects of low-calcium diet on urine calcium excretion, parathyroid function and serum 1,25(OH)2D3 levels in patients with idiopathic hypercalciura and in normal subjects","volume":"72","author":"Coe","year":"1982","journal-title":"Am J Med"},{"key":"10.1016\/j.beem.2014.07.002_bib156","doi-asserted-by":"crossref","first-page":"4937","DOI":"10.1210\/jc.2004-0412","article-title":"Peripheral blood monocyte vitamin D receptor levels are elevated in patients with idiopathic hypercalciuria","volume":"89","author":"Favus","year":"2004","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2014.07.002_bib157","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1152\/ajprenal.00296.2013","article-title":"1,25(OH)2D3-enhanced hypercalciuria in genetic hypercalciuric stone-forming rats fed a low calcium diet","volume":"305","author":"Frick","year":"2013","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.beem.2014.07.002_bib158","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s00223-014-9838-7","article-title":"1,25(OH)2D3 induces a mineralization defect and loss of bone mineral density in genetic hypercalciuric stone-forming rats","volume":"94","author":"Ng","year":"2014","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.beem.2014.07.002_bib159","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1359\/jbmr.091010","article-title":"Elevated vitamin D receptor levels in genetic hypercalciuric stone-forming rats are associated with downregulation of Snail","volume":"25","author":"Bai","year":"2010","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.beem.2014.07.002_bib160","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1542\/peds.2004-0540","article-title":"Effects of anorexia nervosa on clinical, hematologic, biochemical, and bone density parameters in community-dwelling adolescent girls","volume":"114","author":"Misra","year":"2004","journal-title":"Pediatrics"},{"key":"10.1016\/j.beem.2014.07.002_bib161","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1080\/00016340902846080","article-title":"Reduced bone mineral density in adult women diagnosed with menstrual disorders during adolescence","volume":"88","author":"Wiksten-Almstromer","year":"2009","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.beem.2014.07.002_bib162","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1210\/jc.2012-4153","article-title":"Adolescent girls with anorexia nervosa have impaired cortical and trabecular microarchitecture and lower estimated bone strength at the distal radius","volume":"98","author":"Faje","year":"2013","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2014.07.002_bib163","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/eat.22248","article-title":"Fracture risk and areal bone mineral density in adolescent females with anorexia nervosa","volume":"47","author":"Faje","year":"2014","journal-title":"Int J Eat Disord"},{"key":"10.1016\/j.beem.2014.07.002_bib164","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1097\/MED.0b013e32834b4bdc","article-title":"Bone health in anorexia nervosa","volume":"18","author":"Misra","year":"2011","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"10.1016\/j.beem.2014.07.002_bib165","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1210\/jc.2008-2532","article-title":"Increased bone marrow fat in anorexia nervosa","volume":"94","author":"Bredalla","year":"2009","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2014.07.002_bib166","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1001\/archinte.165.4.393","article-title":"Increased prevalence of celiac disease and need for routine screening among patients with osteoporosis","volume":"165","author":"Stenson","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.beem.2014.07.002_bib167","first-page":"112","article-title":"Osteoporosis in a North American adult population with celiac disease","volume":"96","author":"Meyer","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.beem.2014.07.002_bib168","first-page":"2130","article-title":"Bone mineral affection in asymptomatic adult patients with celiac disease","volume":"89","author":"Mazzure","year":"1994","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.beem.2014.07.002_bib169","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0016-5085(03)00891-6","article-title":"Fracture risk in people with celiac disease: a population-based cohort study","volume":"125","author":"West","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.beem.2014.07.002_bib170","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1365-2036.2006.03203.x","article-title":"Celiac disease and the risk of fractures \u2013 a general population-based cohort study","volume":"25","author":"Ludvigsson","year":"2007","journal-title":"Ailment Pharmacol Ther"},{"key":"10.1016\/j.beem.2014.07.002_bib171","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1136\/gut.37.2.220","article-title":"Detection of low bone mineral density by DEXA in unsuspected suboptimally treated coeliac disease","volume":"37","author":"Walters","year":"1995","journal-title":"Gut"},{"key":"10.1016\/j.beem.2014.07.002_bib172","first-page":"1226","article-title":"Bone remodeling indices and secondary hyperparathyroidism in celiac disease","volume":"91","author":"Keaveny","year":"1996","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.beem.2014.07.002_bib173","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s12664-012-0216-y","article-title":"Prevalence and predictors of abnormal bone mineral metabolism in recently diagnosed adult celiac patients","volume":"31","author":"Chakravarthi","year":"2012","journal-title":"Indian J Gastroenterol"},{"key":"10.1016\/j.beem.2014.07.002_bib174","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1080\/003655200750024146","article-title":"Three years\u2019 follow-up of bone density in adult celiac disease: significance of secondary hyperparathyroidism","volume":"35","author":"Valdimmarson","year":"2000","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.beem.2014.07.002_bib175","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1572-0241.1998.00413.x","article-title":"Pre- and post-treatment serum levels of cytokines IL-1b, IL-6, and IL-1 receptor antagonist in celiac disease. Are they related to associated osteopenia?","volume":"93","author":"Fornari","year":"1998","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.beem.2014.07.002_bib176","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1359\/JBMR.040319","article-title":"Imbalance of osteogenesis-regulating factors in patients with celiac disease","volume":"19","author":"Taranta","year":"2004","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.beem.2014.07.002_bib177","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1055\/s-2006-944548","article-title":"Altered osteoprotegerin\/RANKL ratio and low bone mineral density in celiac patients on long-term treatment with glute-free diet","volume":"38","author":"Fiore","year":"2006","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.beem.2014.07.002_bib178","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1159\/000092013","article-title":"Analysis of risk factors for low bone mineral density in inflammatory bowel disease","volume":"73","author":"Frei","year":"2006","journal-title":"Digestion"},{"key":"10.1016\/j.beem.2014.07.002_bib179","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/aje\/kwf007","article-title":"Fracture risk in patients with celiac disease, Crohn's disease, and ulcerative colitis: a nationwide follow-up study of 16,416 patients in Denmark","volume":"156","author":"Vestergaard","year":"2002","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.beem.2014.07.002_bib180","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1053\/gast.2002.34779","article-title":"Long-term fracture risk in patients with Crohn's disease: a population-based study in Olmsted County, Minnesota","volume":"123","author":"Loftus","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.beem.2014.07.002_bib181","doi-asserted-by":"crossref","first-page":"795","DOI":"10.7326\/0003-4819-133-10-200011210-00012","article-title":"The incidence of fracture among patients with inflammatory bowel disease. A population-based cohort study","volume":"133","author":"Bernstein","year":"2000","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.beem.2014.07.002_bib182","doi-asserted-by":"crossref","first-page":"5560","DOI":"10.3748\/wjg.v13.i42.5560","article-title":"Novel genetic markers in inflammatory bowel disease","volume":"13","author":"Rodriguez-Bores","year":"2007","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.beem.2014.07.002_bib183","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1046\/j.1365-2036.2002.01363.x","article-title":"Metabolic bone disease is present at diagnosis in patients with inflammatory bowel disease","volume":"16","author":"Lamb","year":"2002","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.beem.2014.07.002_bib184","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1177\/0148607110381267","article-title":"Vitamin D deficiency in patients with inflammatory bowel disease: association with disease activity and quality of life","volume":"35","author":"Ulitsky","year":"2011","journal-title":"JPEN"},{"key":"10.1016\/j.beem.2014.07.002_bib185","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.crohns.2013.09.008","article-title":"Dietary calcium intake in patients with inflammatory bowel disease","volume":"8","author":"Vernia","year":"2014","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1016\/j.beem.2014.07.002_bib186","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s00198-005-0016-7","article-title":"Ileum resection is the most predictive factor for osteoporosis in patients with Crohn's disease","volume":"17","author":"van Hogezand","year":"2006","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.beem.2014.07.002_bib187","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1136\/gut.2004.044370","article-title":"The RANKL\/OPG system is activated in inflammatory bowel disease and relates to the state of bone loss","volume":"54","author":"Moschen","year":"2005","journal-title":"Gut"},{"key":"10.1016\/j.beem.2014.07.002_bib188","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1001\/jama.2014.732","article-title":"Prevalence of childhood and adult obesity in the United States, 2011\u20132012","volume":"311","author":"Ogden","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.beem.2014.07.002_bib189","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1007\/s11695-009-0014-5","article-title":"Metabolic\/bariatric surgery Worldwide 2008","volume":"19","author":"Buchwald","year":"2009","journal-title":"Obes Surg"},{"key":"10.1016\/j.beem.2014.07.002_bib190","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1007\/s11695-009-9843-5","article-title":"Evaluation of bone disease in morbidly obese women after gastric bypass and risk factors implicated in bone loss","volume":"19","author":"Vilarrasa","year":"2009","journal-title":"Obes Surg"},{"key":"10.1016\/j.beem.2014.07.002_bib191","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1007\/s11695-013-1016-x","article-title":"Effect of bariatric surgery on bone mineral density: comparison of gastric bypass and sleeve gastrectomy","volume":"23","author":"Vilarrasa","year":"2013","journal-title":"Obes Surg"},{"key":"10.1016\/j.beem.2014.07.002_bib192","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1002\/jbmr.2226","article-title":"Bone metabolism after bariatric surgery","volume":"29","author":"Yu","year":"2014","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.beem.2014.07.002_bib193","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1038\/oby.2011.133","article-title":"Increased PTH and 1,25OH2D levels associated with increased markers of bone turnover following bariatric surgery","volume":"19","author":"Sinha","year":"2011","journal-title":"Obesity"},{"key":"10.1016\/j.beem.2014.07.002_bib194","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1007\/s11695-014-1179-0","article-title":"Changes in bone mineral density after sleeve gastrectomy or gastric bypass: relationships with variations in vitamin D, ghrelin, and adiponectin levels","volume":"24","author":"Carrasco","year":"2014","journal-title":"Obes Surg"},{"key":"10.1016\/j.beem.2014.07.002_bib195","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1359\/JBMR.041237","article-title":"Ghrelin directly regulates bone formation","volume":"20","author":"Fukushima","year":"2005","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.beem.2014.07.002_bib196","first-page":"1","article-title":"Bone metabolism status and associated risk factors in elderly patients with COPD","author":"Xiaomei","year":"2014","journal-title":"Cell Biochem Biophys"},{"key":"10.1016\/j.beem.2014.07.002_bib197","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1378\/chest.128.4.2099","article-title":"Patterns of comorbidities in newly diagnosed COPD and asthma in primary care","volume":"128","author":"Soriano","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.beem.2014.07.002_bib198","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1164\/rccm.201004-0666OC","article-title":"Radiographic emphysema predicts low bone mineral density in a tobacco -exposed cohort","volume":"183","author":"Bon","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.beem.2014.07.002_bib199","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1164\/rccm.200406-754OC","article-title":"Associated loss of fat-free mass and bone mineral density in chronic obstructive pulmonary disease","volume":"170","author":"Bolton","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.beem.2014.07.002_bib200","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1183\/09031936.05.00058204","article-title":"Severity of obstructive airway disease and risk of osteoporotic fracture","volume":"25","author":"de Vries","year":"2005","journal-title":"Eur Respir J"},{"key":"10.1016\/j.beem.2014.07.002_bib201","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1136\/thx.2011.160028","article-title":"Risk of fractures with inhaled corticosteroids in COPD: a systematic review and meta-analysis of randomised controlled trials and observational studies","volume":"66","author":"Loke","year":"2011","journal-title":"Thorax"},{"key":"10.1016\/j.beem.2014.07.002_bib202","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1136\/thx.2003.019588","article-title":"Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis","volume":"59","author":"Gan","year":"2004","journal-title":"Thorax"},{"key":"10.1016\/j.beem.2014.07.002_bib203","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3109\/07853890.2012.671536","article-title":"Vitamin D status is associated with bone mineral density and functional exercise capacity in patients with chronic obstructive pulmonary disease","volume":"45","author":"Romme","year":"2013","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.beem.2014.07.002_bib204","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s001980050063","article-title":"Reduced pulmonary function in patients with osteoporotic fractures","volume":"8","author":"Schlaich","year":"1998","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.beem.2014.07.002_bib205","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1210\/jc.2009-0205","article-title":"Approach to the patient with transplantation-related bone loss","volume":"94","author":"Ebeling","year":"2009","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2014.07.002_bib206","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1359\/jbmr.2003.18.12.2083","article-title":"Disorders associated with acute rapid and severe bone loss","volume":"18","author":"Epstein","year":"2003","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.beem.2014.07.002_bib207","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1210\/endo-123-5-2571","article-title":"Cyclosporin-A in\u00a0vivo produces severe osteopenia in the rat: effect of dose and duration of administration","volume":"123","author":"Movsowitz","year":"1988","journal-title":"Endocrinology"},{"key":"10.1016\/j.beem.2014.07.002_bib208","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1007\/s00774-004-0523-1","article-title":"Regulation of bone metabolism in immunosuppressant (FK506)-treated rats","volume":"22","author":"Kirino","year":"2004","journal-title":"J\u00a0Bone Miner Metab"},{"key":"10.1016\/j.beem.2014.07.002_bib209","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/jbmr.5650040314","article-title":"Cyclosporin A in the oophorectomized rat: unexpected severe bone resorption","volume":"4","author":"Movsowitz","year":"1989","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.beem.2014.07.002_bib210","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/BF02556217","article-title":"Effects of cyclosporine A in chick osteoclasts in\u00a0vitro","volume":"49","author":"Chowdhury","year":"1991","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.beem.2014.07.002_bib211","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1210\/endo.137.6.8641176","article-title":"T\u00a0lymphocytes play a critical role in the development of cyclosporin A-induced osteopenia","volume":"137","author":"Buchinsky","year":"1996","journal-title":"Endocrinology"},{"key":"10.1016\/j.beem.2014.07.002_bib212","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0002-9343(97)00142-3","article-title":"Bone mass, vitamin D deficiency and hyperparathyroidism in congestive heart failure","volume":"103","author":"Shane","year":"1997","journal-title":"Am J Med"},{"key":"10.1016\/j.beem.2014.07.002_bib213","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1210\/jc.2011-3055","article-title":"Heart failure is a clinically and densitometrically independent and novel risk factor for major osteoporotic fractures: population-based cohort study of 45,509 subjects","volume":"97","author":"Majumdar","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2014.07.002_bib214","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.jadohealth.2006.03.011","article-title":"Depot medroxyprogesterone acetate and bone mineral density in adolescents\u2013the Black Box Warning: a position paper for the Society of Adolescent Medicine","volume":"39","author":"Cromer","year":"2006","journal-title":"J\u00a0Adolesc Health"},{"key":"10.1016\/j.beem.2014.07.002_bib215","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1136\/bmj.303.6793.13","article-title":"Bone density in women receiving depot medroxyprogesterone acetate for contraception","volume":"303","author":"Cundy","year":"1991","journal-title":"BMJ"},{"key":"10.1016\/j.beem.2014.07.002_bib216","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.contraception.2005.12.010","article-title":"Progestin-only contraception and bone mineral density: a systematic review","volume":"73","author":"Curtis","year":"2006","journal-title":"Contraception"},{"key":"10.1016\/j.beem.2014.07.002_bib217","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1016\/j.fertnstert.2006.05.024","article-title":"Bone mineral density loss and recovery during 48 months in first-time users of depot medroxyprogesterone acetate","volume":"86","author":"Clark","year":"2006","journal-title":"Fertil Steril"},{"key":"10.1016\/j.beem.2014.07.002_bib218","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.contraception.2007.10.005","article-title":"Bone density recovery after depot medroxyprogesterone acetate injectable contraception use","volume":"77","author":"Kaunitz","year":"2008","journal-title":"Contraception"},{"key":"10.1016\/j.beem.2014.07.002_bib219","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1359\/jbmr.060508","article-title":"Effect of an aromatase inhibitor on BMD and bone turnover markers: 2-year results of the Anastrazole, Tamoxifen, Alone, or in Combination (ATAC) trial (18233230)","volume":"21","author":"Eastell","year":"2006","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.beem.2014.07.002_bib220","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1200\/JCO.2007.11.0726","article-title":"Effect of anastrazole on bone mineral density: 5-year results from the anastrazole, tamoxifen, alone, or in combination trial 18233230","volume":"26","author":"Eastell","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.beem.2014.07.002_bib221","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S1470-2045(07)70385-6","article-title":"Effect of anastrazole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial","volume":"9","author":"Forbes","year":"2008","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.beem.2014.07.002_bib222","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1093\/annonc\/mdu008","article-title":"Fracture incidence after 3 years of aromatase inhibitor therapy","volume":"25","author":"Bouvard","year":"2014","journal-title":"Ann Oncol"},{"key":"10.1016\/j.beem.2014.07.002_bib223","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.breast.2011.09.001","article-title":"Bone health in a prospective cohort of postmenopausal women receiving aromatase inhibitors for early breast cancer","volume":"21","author":"Servitja","year":"2012","journal-title":"Breast"},{"key":"10.1016\/j.beem.2014.07.002_bib224","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1210\/en.2004-0735","article-title":"Rosiglitazone causes bone loss in mice by suppressing osteoblast differentiation and bone formation","volume":"146","author":"Ali","year":"2005","journal-title":"Endocrinology"},{"key":"10.1016\/j.beem.2014.07.002_bib225","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.trsl.2012.08.006","article-title":"The effects of thiazolinediones on human bone marrow stromal cell differentiation in\u00a0vitro and in thiazolinedione-treated patients with type 2 diabetes","volume":"161","author":"Beck","year":"2013","journal-title":"Transl Res"},{"key":"10.1016\/j.beem.2014.07.002_bib226","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1042\/bj20030426","article-title":"Peroxisome-proliferator-activator receptor gamma suppresses Wnt\/beta-catenin signaling during adipogenesis","volume":"376","author":"Moldes","year":"2003","journal-title":"Biochem J"},{"key":"10.1016\/j.beem.2014.07.002_bib227","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1210\/en.2006-1121","article-title":"Activation of peroxisome proliferator-activator gamma by roiglitazone suppresses components of the insulin-like growth factor regulatory system in\u00a0vitro and in\u00a0vivo","volume":"148","author":"Lecka-Czarnik","year":"2007","journal-title":"Endocrinology"},{"key":"10.1016\/j.beem.2014.07.002_bib228","doi-asserted-by":"crossref","first-page":"845","DOI":"10.2337\/dc07-2270","article-title":"Rosiglitazone-associated fractures in type 2 diabetes: an analysis from a diabetes outcome progression trial (ADOPT)","volume":"31","author":"Kahn","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/j.beem.2014.07.002_bib229","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1210\/jc.2009-0572","article-title":"Effect of rosiglitazone, metformin, and glyburide on bone biomarkers in patients with type 2 diabetes","volume":"95","author":"Zinman","year":"2010","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2014.07.002_bib230","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1503\/cmaj.080486","article-title":"Long term use of thiazolinediones and fracture in type 2 diabetes: a meta-analysis","volume":"180","author":"Loke","year":"2009","journal-title":"CMAJ"},{"key":"10.1016\/j.beem.2014.07.002_bib231","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1093\/oxfordjournals.aje.a009171","article-title":"Risk factors for hip fracture in men. Hip Fracture Study Group","volume":"145","author":"Grisso","year":"1997","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.beem.2014.07.002_bib232","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1001\/jama.296.24.2947","article-title":"Long-term proton pump inhibitor therapy and risk of hip fracture","volume":"296","author":"Yang","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.beem.2014.07.002_bib233","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/s00223-006-0021-7","article-title":"Proton pump inhibitors, histamine H2 receptor antagonists, and other antacid medications and the risk of fracture","volume":"79","author":"Vestergaard","year":"2006","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.beem.2014.07.002_bib234","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1001\/archinternmed.2010.94","article-title":"Proton pump inhibitor use, hip fracture, and change in bone mineral density in postmenopausal women: results from the Women's Health Initiative","volume":"170","author":"Gray","year":"2010","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.beem.2014.07.002_bib235","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s00223-008-9170-1","article-title":"Acid-suppressive medications and risk of bone loss and fracture in older adults","volume":"83","author":"Yu","year":"2008","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.beem.2014.07.002_bib236","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1093\/ndt\/10.8.1376","volume":"10","author":"Graziani","year":"1995","journal-title":"Nephrol Dial Transpl"},{"key":"10.1016\/j.beem.2014.07.002_bib237","doi-asserted-by":"crossref","first-page":"2786","DOI":"10.1002\/jbmr.166","article-title":"Do proton pump inhibitors decrease calcium absorption?","volume":"25","author":"Hansen","year":"2010","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.beem.2014.07.002_bib238","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1177\/009127000004001108","article-title":"Pharmacokinetic and pharmacodynamic comparison of two calcium supplements in postmenopausal women","volume":"40","author":"Heller","year":"2000","journal-title":"J\u00a0Clin Pharmacol"},{"key":"10.1016\/j.beem.2014.07.002_bib239","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1212\/WNL.58.9.1348","article-title":"Effect of antiepileptic drugs on bone density in ambulatory patients","volume":"58","author":"Farhat","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.beem.2014.07.002_bib240","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1111\/j.0013-9580.2004.18804.x","article-title":"Fracture risk associated with use of antiepileptic drugs","volume":"45","author":"Vestergaard","year":"2004","journal-title":"Epilepsia"},{"key":"10.1016\/j.beem.2014.07.002_bib241","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.amjopharm.2010.02.003","article-title":"A\u00a0review of the effect of anticonvulsant medications on bone mineral density and fracture risk","volume":"8","author":"Lee","year":"2010","journal-title":"Am J Geriatr Pharmacother"},{"key":"10.1016\/j.beem.2014.07.002_bib242","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1177\/1759720X11410769","article-title":"Antiepileptics and bone health","volume":"3","author":"Meier","year":"2011","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"10.1016\/j.beem.2014.07.002_bib243","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1212\/01.wnl.0000247107.54562.0e","article-title":"Fuleihan Gel-H. Two randomized vitamin D trials in ambulatory patients on anticonvulsants: impact on bone","volume":"67","author":"Mikati","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.beem.2014.07.002_bib244","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4158\/EP12119.OR","article-title":"The association of newer anticonvulsant medications and bone mineral density","volume":"14","author":"Lee","year":"2012","journal-title":"Endocr Pract"},{"key":"10.1016\/j.beem.2014.07.002_bib245","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S8756-3282(01)00593-2","article-title":"Neurotransmitter action in osteoblasts: expression of a functional system for serotonin receptor activation and reuptake","volume":"29","author":"Bliziotes","year":"2001","journal-title":"Bone"},{"key":"10.1016\/j.beem.2014.07.002_bib246","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s00198-012-1975-0","article-title":"Depressive symptoms and rates of bone loss at the hip in older men","volume":"24","author":"Diem","year":"2013","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.beem.2014.07.002_bib247","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1001\/archinte.167.12.1246","article-title":"Association of low bone mineral density with selective serotonin reuptake inhibitor use by older men","volume":"167","author":"Haney","year":"2007","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.beem.2014.07.002_bib248","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1001\/archinte.167.2.188","article-title":"Effect of selective serotonin reuptake inhibitors on the risk of fracture","volume":"167","author":"Richards","year":"2007","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.beem.2014.07.002_bib249","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1001\/archinte.167.12.1240","article-title":"Use of antidepressants and rates of hip bone loss in older women: the study of osteoporotic fractures","volume":"167","author":"Diem","year":"2007","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.beem.2014.07.002_bib250","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s11606-008-0525-0","article-title":"Depressive symptoms, bone loss, and fractures in postmenopausal women","volume":"23","author":"Spangler","year":"2008","journal-title":"J\u00a0Gen Intern Med"},{"key":"10.1016\/j.beem.2014.07.002_bib251","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1016\/j.amjmed.2005.07.033","article-title":"Bone mineral density in subjects using central nervous system-active medications","volume":"118","author":"Kinjo","year":"2005","journal-title":"Am J Med"},{"key":"10.1016\/j.beem.2014.07.002_bib252","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1007\/s00198-014-2649-x","article-title":"Antidepressant use and 10-year incident fracture risk: the population-based Canadian Multicentre Osteoporosis Study (CaMoS)","volume":"25","author":"Moura","year":"2014","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.beem.2014.07.002_bib253","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.cell.2008.09.059","article-title":"Lrp5 controls bone formation by inhibiting serotonin synthesis in the duodenum","volume":"135","author":"Yadav","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.beem.2014.07.002_bib254","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1111\/j.1471-0528.1983.tb06459.x","article-title":"Prolonged heparin therapy in pregnancy causes bone demineralization","volume":"90","author":"de Sweit","year":"1983","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.beem.2014.07.002_bib255","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/S0002-9378(94)70299-3","article-title":"A\u00a0prospective study of heparin-induced osteoporosis in pregnancy using bone densitometry","volume":"170","author":"Barbour","year":"1994","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.beem.2014.07.002_bib256","doi-asserted-by":"crossref","first-page":"3236","DOI":"10.1182\/blood.V89.9.3236","article-title":"A\u00a0histomorphometric comparison of the effects of heparin and low-molecular-weight heparin on cancellous bone in rats","volume":"89","author":"Muir","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.beem.2014.07.002_bib257","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/j.1365-2796.2006.01695.x","article-title":"Effects of antihypertensive drug treatments on fracture outcomes: a meta-analysis of observational studies","volume":"260","author":"Wiens","year":"2006","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.beem.2014.07.002_bib258","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1007\/s00198-013-2369-7","article-title":"The risk of falls on initiation of antihypertensive drugs in the elderly","volume":"24","author":"Butt","year":"2013","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.beem.2014.07.002_bib259","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1359\/JBMR.051003","article-title":"Loop diuretics increase bone turnover and decrease BMD in osteopenic postmenopausal women: results from a randomized controlled study with bumetenide","volume":"21","author":"Rejnmark","year":"2006","journal-title":"J\u00a0Bone Miner Res"}],"container-title":["Best Practice &amp; Research Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X14000761?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X14000761?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T16:49:01Z","timestamp":1761497341000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521690X14000761"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":259,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["S1521690X14000761"],"URL":"https:\/\/doi.org\/10.1016\/j.beem.2014.07.002","relation":{},"ISSN":["1521-690X"],"issn-type":[{"value":"1521-690X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Secondary osteoporosis: Pathophysiology & diagnosis","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beem.2014.07.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}